Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Myriad Genetics, Inc. (NASDAQ: MYGN)
MYGN Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
0.50%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-20.50%
MYGN Stock Analysis
MYGN
PE Ratio:
MYGN
PEG Ratio:
MYGN
Forward EPS Growth (12 month):
220.80%
MYGN
PS Ratio:
0.5
MYGN
PSG Ratio:
0.1
MYGN
Forward Revenue Growth (12 month):
5.90%
MYGN Articles
No data was found